2017
Mumbai (India)
Series C
MakeO is a leading clinical beauty and health tech platform in India, specializing in advanced dental, skin and hair cosmetic treatments. The company operates across more than 21 cities in India and has expanded to five cities in the GCC region, establishing itself as a prominent player in the clinical beauty and health tech industry.
Clear Aligners: Invisible dental braces for teeth straightening (toothsi).
Laser Hair Reduction: Painless, dermatologist-backed hair removal.
Skin Treatments: Facials, acne care, anti-aging and skin rejuvenation (skinnsi).
Hair Treatments: Advanced solutions for hair fall and scalp health.
Teeth Whitening: Professional whitening at home or in clinics.
Experience Centres & At-Home Services: Treatments available at over 30 centres or conveniently at home.
All services are tech-enabled, clinically supervised and designed for safe, effective results.
makeO generates revenue primarily through the following channels and its Revenue Streams.
Direct Sales of Dental Aligners: The sale of clear aligners under the toothsi brand is the largest revenue contributor, accounting for approximately 69% of total operating revenue. In FY24, aligner sales grew to Rs 124 crore.
Skin and Hair Treatment Services: Revenue from skinnsi services includes laser hair reduction, facials, anti-aging, acne treatments and related skincare products. These services complement the dental segment and drive cross-selling opportunities.
Product Sales: makeO also sells dental hygiene and skincare products, adding an additional stream of direct-to-consumer revenue.
Subscription and Treatment Packages: Customers can opt for bundled treatment plans and subscription-based services for ongoing skin, hair or dental care, providing predictable recurring revenue.
Experience Centres: Offline centers serve as both service delivery points and retail outlets, enhancing customer engagement and upselling opportunities.
B2C: The primary segment is individual consumers seeking cosmetic dental, skin or hair treatments, especially urban millennials and young professionals.
B2B: Potential partnerships with clinics, dentists and beauty professionals to expand reach and leverage makeO’s technology and products.
Geographic Expansion: Continued rollout of experience centers in new Indian cities and GCC markets, supported by recent funding rounds.
Product Innovation: Introduction of new clinical-grade treatments, expansion of product lines and investment in R&D for advanced cosmetic solutions.
Digital-First Experience: Enhancing the online platform for seamless consultations, progress tracking and aftercare, driving customer retention.
Strategic Partnerships: Collaborations with healthcare providers, influencers and technology partners to broaden service offerings and market penetration.
$105 Million
10
$16.0 Million, Series C
as of January 9, 2024
$272 Million
as of January 10, 2024
2.59×
as of January 10, 2024
Eight Roads Ventures
and 6 more178
Avataar Skincare
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
January 9, 2024 | Series C | $16.0 Million | $272.0 Million | $22.0 Million | 11.3x | Eight Roads Ventures, Paramark Ventures, Siddhant Partners, KB Investment , 360 One, Tahseen, Rba Finance and Investment |
February 14, 2023 | Series C | $4.8 Million | $317.0 Million | $20.8 Million | - | Kingsway Frontier Consumer Opportunities FCO Growth Fund, LS1-FZCO, FJ Labs, Tona Investments, Eight Roads Ventures, Siddhant Partners ,Tahseen, Siddharth Shah Family Trust, Goldfinger Investment Holding, MPGI |
April 12, 2022 | Series C | $40.5 Million | $257.0 Million | $11.5 Million | - | Eight Roads Ventures, Paramark Ventures, Mankekar Family Office, KB Investment, Think Investments, JM Financial Private Equity , IIFL Finance |
September 3, 2021 | Series B | $14.1 Million | $128.0 Million | $6.3 Million | - | Alteria Capital, JM Financial Private Equity, Stride Ventures, Logx Venture Partners ,Aspire Financial Consulting |
August 6, 2021 | Series A | $20.0 Million | $104.0 Million | $5.6 Million | - | Eight Roads Ventures, Mankekar Family Office, Think Investments |
January 9, 2021 | Series A | $5.2 Million | $25.8 Million | $1.8 Million | 11.2x | Think Investments, JM Financial Private Equity ,PharmEasy |
August 13, 2020 | Series A | $602.0 K | $1.3 Million | $1.3 Million | 0.5x | JM Financial Private Equity |
November 27, 2017 | Seed | $1.0 Million | - | - | - | - |